Inhaled Microbiomics, Pharmaceutical Formulation and Disease Considerations in Patients with Cystic Fibrosis

Authors

David A. McChesney, University of New Mexico, College of Pharmacy, Department of Pharmaceutical Sciences
Aidan Leyba, University of New Mexico, College of Pharmacy, Department of Pharmaceutical Sciences
Mohammad Razmjoo, University of New Mexico, College of Pharmacy, Department of Pharmaceutical Sciences
Pavan Muttil, University of New Mexico, College of Pharmacy, Department of Pharmaceutical Sciences

Document Type

Poster

Publication Date

4-17-2023

Comments

Presented at: Research & Scholarship Day 2023

Recommended Citation

McChesney, David A.; Aidan Leyba; Mohammad Razmjoo; and Pavan Muttil. "Inhaled Microbiomics, Pharmaceutical Formulation and Disease Considerations in Patients with Cystic Fibrosis." (2023). https://digitalrepository.unm.edu/hsc_arsd/8